Americas vs Norway: Proportion of the target population who received the final dose of
Americas
64.0%
in 2024
Norway
91.0%
in 2024
Americas rank
6th
Norway rank
9th
Proportion of the target population who received the final dose of over time
- Americas
- Norway
How they compare
Norway currently reports 91.0% against 64.0% in Americas, a difference of 27.0%.
That makes Norway's figure about 1.4 times Americas's.
Across all 15 years both countries report, Norway has been ahead every year.
Americas ranks 6th and Norway ranks 9th of 35 groups.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.1% | 78.5% | 41.4% | Norway |
| 2020s | 50.8% | 90.6% | 39.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Americas or Norway?
- Norway, at 91.0% against 64.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Americas and Norway?
- 27.0%, with Norway ahead.
- How many years of comparable data are there for Americas and Norway?
- 15 years are reported by both, from 2010 to 2024.
- How do Americas and Norway rank globally for proportion of the target population who received the final dose of?
- Americas ranks 6th and Norway ranks 9th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.